Indeed Kalenn a modest time to wait for big gain no rush lets...

First 25 Last

Share
Profile

Follow
lecram

3,185 Posts.

189

02/12/20

17:35

Post #: 49303385
Share

Originally posted by Kalenn: ↑

IMO the only real risk here is the opportunity cost if it takes longer than expected. I do not imagine for one second that the Myanmar government would want to; a) sully their reputation in international investment markets, b) miss out on the cudos of the jobs generated in an high unemployment rural area or miss out for years to come on that important PSA agreement money. The spreadsheets I throw up are also an indication of the enormous sums that will flow to government within 2 to 3 years once MIC license granted.

Yes, technically, there is a risk that something could go seriously wrong but that risk is getting increasingly small and has been approaching zero for the past 3 years. The above are just a few of the risk mitigating factors.

Every event that takes us closer to finalisation of the MIC also takes the risk closer to zero and the reward closer to substantial!

You can remove all risk for yourself by selling, but of course that removes all chance of success as well.

In the meantime, the company states clearly that they expect the invitation to submit the MIC to arrive this month. If they thought differently I believe they would notify the market. I fully expect they will receive the invitation to submit MIC application within weeks. Most likely in December but if not then shortly after.

The company (and who is in a better position to judge this?) has suggested December submission and typically an 8 week process to get through to the awarding of the MIC licence.

Even though I too would like it yesterday, it seems a very modest time to wait.

Expand

Indeed Kalenn a modest time to wait for big gain no rush lets enjoy the Holiday season it will all come to fruition at some point.

MYL Price at posting: 7.6¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 159 more messages in this thread...

First 25 Last

Add MYL (ASX) to my watchlist

Indeed Kalenn a modest time to wait for big gain no rush lets...

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News